Related references
Note: Only part of the references are listed.Plasma androgens and the presence and course of depression in a large cohort of women
Anouk E. de Wit et al.
TRANSLATIONAL PSYCHIATRY (2021)
A prospective, phase II, single-centre, cross-sectional, randomised study investigating Dehydroepiandrosterone supplementation and its Profile in Trauma: ADaPT
Conor Bentley et al.
BMJ OPEN (2021)
11-Oxygenated androgens in health and disease
Adina F. Turcu et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
Susan R. Davis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials
Catherine M. Jankowski et al.
CLINICAL ENDOCRINOLOGY (2019)
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility
M. F. Costello et al.
HUMAN REPRODUCTION OPEN (2019)
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health
Stephanie S. Faubion et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2018)
Intracrine androgen biosynthesis, metabolism and action revisited
Lina Schiffer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Dehydroepiandrosterone (DHEA) for Depression: A Systematic Review and Meta-analysis
Clayton Peixoto et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2018)
Metabolic and isotopic signature of short-term DHEA administration in women: Comparison with findings in men
Corinne Buisson et al.
DRUG TESTING AND ANALYSIS (2018)
Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 μg estradiol on symptoms of vulvovaginal atrophy
David F. Archer et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause
Fernand Labrie et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis
J. C. Qin et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2017)
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society
D. J. Portman et al.
CLIMACTERIC (2014)
Dehydroepiandrosterone (DHEA): Hypes and Hopes
Krzysztof Rutkowski et al.
DRUGS (2014)
The Benefits and Harms of Systemic Dehydroepiandrosterone (DHEA) in Postmenopausal Women With Normal Adrenal Function: A Systematic Review and Meta-analysis
Tarig Elraiyah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
Margaret E. Wierman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Endocrine consequences of anorexia nervosa
Madhusmita Misra et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens
Fernand Labrie et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
DHEA Replacement for Postmenopausal Women
Susan R. Davis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
The Approach to the Adult with Newly Diagnosed Adrenal Insufficiency
Wiebke Arlt
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Dehydroepiandrosterone Therapy on Pubic Hair Growth and Psychological Well-Being in Adolescent Girls and Young Women with Central Adrenal Insufficiency: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial
G. Binder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials of DHEA Treatment Effects on Quality of Life in Women with Adrenal Insufficiency
Aziz A. Alkatib et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Long-term DHEA replacement in primary adrenal insufficiency: A randomized, controlled trial
Eleanor M. Gurnell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Increases in Bone Mineral Density in Response to Oral Dehydroepiandrosterone Replacement in Older Adults Appear to Be Mediated by Serum Estrogens
Catherine M. Jankowski et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults:: the DAWN trial
D. von Muehlen et al.
OSTEOPOROSIS INTERNATIONAL (2008)
DHEA in elderly women and DHEA or testosterone in elderly men
K. Sreekumaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Androgen therapy in women: An endocrine society clinical practice guideline
Margaret E. Wierman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells
AJ Coles et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: A randomized, placebo-controlled, cross-over trial
SW van Thiel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effect of DHEA on abdominal fat and insulin action in elderly women and men - A randomized controlled trial
DT Villareal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effect of 1-year oral administration of dehydroepiandrosterone to 60-to 80-year-old individuals on muscle function and cross-sectional area - A double-blind placebo-controlled trial
G Percheron et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Replacement of dehydroepiandrosterone in adrenal failure:: No benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial
K Lovås et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The effect of dehydroepiandrosterone (DHEA) on recognition memory decision processes and discrimination in postmenopausal women
E Hirshman et al.
PSYCHONOMIC BULLETIN & REVIEW (2003)
Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: A randomized trial
CM Gordon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging:: Contribution of the DHEAge Study to a sociobiomedical issue
EE Baulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
